Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Intas Pharmaceuticals Limited | Ahmedabad, India | Makes it and tests it | No problems foundJul 12, 2024 · 10 inspections |
Recalls
- Feb 7, 2023 · Class II · Accord Healthcare, Inc.
CGMP Deviations: recalling drug products following an FDA inspection.
Lots: Batches: P2105532, Exp. Date 6/30/2024; P2200348, Exp. Date 12/31/2024; - Feb 7, 2023 · Class II · Accord Healthcare, Inc.
CGMP Deviations: recalling drug products following an FDA inspection.
Lots: Batches: a) P2200530, Exp. Date 12/31/2024; b) P2105583, Exp. Date 6/30/2024; - Feb 7, 2023 · Class II · Accord Healthcare, Inc.
CGMP Deviations: recalling drug products following an FDA inspection.
Lots: Batches: P2105483, Exp. Date 7/31/2024; - Feb 7, 2023 · Class II · Accord Healthcare, Inc.
CGMP Deviations: recalling drug products following an FDA inspection.
Lots: Batches: P2105472, Exp. Date 4/30/2024; - Feb 7, 2023 · Class II · Accord Healthcare, Inc.
CGMP Deviations: recalling drug products following an FDA inspection.
Lots: Batches: P2105551, Exp. Date 7/31/2024;
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buspirone: every company that makes it
- Form
- tablet, oral
- Strength
- 7.5 mg
- Approval
- ANDA ANDA202557
- On the market since
- Nov 14, 2016
- Package NDCs
16729-201-0116729-201-1616729-201-17- Official label
- DailyMed (National Library of Medicine), updated Oct 7, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?